These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9823026)
1. Differential influence of fasting and BM13.907 treatment on growth and phenotype of pressure overloaded rat heart. Rupp H; Elimban V; Dhalla NS Mol Cell Biochem; 1998 Nov; 188(1-2):209-15. PubMed ID: 9823026 [TBL] [Abstract][Full Text] [Related]
2. Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium. Turcani M; Thormaehlen D; Rupp H Br J Pharmacol; 2004 Nov; 143(5):561-72. PubMed ID: 15466442 [TBL] [Abstract][Full Text] [Related]
3. Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy. Turcani M; Rupp H Mol Cell Biochem; 2000 Sep; 212(1-2):219-25. PubMed ID: 11108154 [TBL] [Abstract][Full Text] [Related]
4. Characterization of sucrose-induced changes in cardiac phenotype. Rupp H; Wahl R; Maisch B; Hansen M Pflugers Arch; 2002 Oct; 445(1):32-9. PubMed ID: 12397384 [TBL] [Abstract][Full Text] [Related]
5. Subcellular remodeling and heart dysfunction in cardiac hypertrophy due to pressure overload. Dhalla NS; Golfman L; Liu X; Sasaki H; Elimban V; Rupp H Ann N Y Acad Sci; 1999 Jun; 874():100-10. PubMed ID: 10415524 [TBL] [Abstract][Full Text] [Related]
6. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. Rupp H; Elimban V; Dhalla NS FASEB J; 1992 Mar; 6(6):2349-53. PubMed ID: 1531968 [TBL] [Abstract][Full Text] [Related]
7. Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan. Turcani M; Rupp H Mol Cell Biochem; 1998 Nov; 188(1-2):225-33. PubMed ID: 9823028 [TBL] [Abstract][Full Text] [Related]
8. Early changes in the functions of cardiac sarcoplasmic reticulum in volume-overloaded cardiac hypertrophy in rats. Hisamatsu Y; Ohkusa T; Kihara Y; Inoko M; Ueyama T; Yano M; Sasayama S; Matsuzaki M J Mol Cell Cardiol; 1997 Apr; 29(4):1097-109. PubMed ID: 9160862 [TBL] [Abstract][Full Text] [Related]
9. Metabolically-modulated growth and phenotype of the rat heart. Rupp H; Jacob R Eur Heart J; 1992 Sep; 13 Suppl D():56-61. PubMed ID: 1396861 [TBL] [Abstract][Full Text] [Related]
10. Cardiac hypertrophy: old concepts, new perspectives. Gupta M; Gupta MP Mol Cell Biochem; 1997 Nov; 176(1-2):273-9. PubMed ID: 9406172 [TBL] [Abstract][Full Text] [Related]
11. Effect of intermittent administration of sustained release isosorbide dinitrate (sr-ISDN) in rats with pressure-overload heart. Shimamura S; Endo H; Kutsuna H; Kobayashi M; Hirao H; Shimizu M; Tanaka R; Yamane Y J Vet Med Sci; 2006 Mar; 68(3):213-7. PubMed ID: 16598163 [TBL] [Abstract][Full Text] [Related]
12. Sarcoplasmic reticulum genes are upregulated in mild cardiac hypertrophy but downregulated in severe cardiac hypertrophy induced by pressure overload. Arai M; Suzuki T; Nagai R J Mol Cell Cardiol; 1996 Aug; 28(8):1583-90. PubMed ID: 8877769 [TBL] [Abstract][Full Text] [Related]
13. Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy. Jiang QJ; Xu G; Mao FF; Zhu YF J Zhejiang Univ Sci B; 2006 Mar; 7(3):228-34. PubMed ID: 16502511 [TBL] [Abstract][Full Text] [Related]
14. Effects of long-term hydralazine treatment on myocardial structure and expression of myosin isogenes in cardiac pressure overload in rats. Reddy DS; Singh M; Ganguly NK Methods Find Exp Clin Pharmacol; 1996 May; 18(4):261-71. PubMed ID: 8803958 [TBL] [Abstract][Full Text] [Related]
15. Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan. Liu X; Sentex E; Golfman L; Takeda S; Osada M; Dhalla NS Clin Exp Hypertens; 1999; 21(1-2):145-56. PubMed ID: 10052650 [TBL] [Abstract][Full Text] [Related]
16. Effects of dantrolene sodium on progression of left ventricular hypertrophy induced by pressure overload in rats. Ohkusa T; Hisamatsu Y; Ueyama T; Kobayashi S; Yano M; Maekawa T; Matsuzaki M J Cardiovasc Pharmacol; 1998 Apr; 31(4):520-4. PubMed ID: 9554799 [TBL] [Abstract][Full Text] [Related]
17. Altered cardiac mechanism and sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy in rats. Ohkusa T; Hisamatsu Y; Yano M; Kobayashi S; Tatsuno H; Saiki Y; Kohno M; Matsuzaki M J Mol Cell Cardiol; 1997 Jan; 29(1):45-54. PubMed ID: 9040020 [TBL] [Abstract][Full Text] [Related]
18. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation. Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734 [TBL] [Abstract][Full Text] [Related]
19. Modulation of myosin in right ventricular hypertrophy. Wikman-Coffelt J; Lotysh M; Fenner C; Zelis R; Mason DT Recent Adv Stud Cardiac Struct Metab; 1975; 8():437-46. PubMed ID: 129838 [TBL] [Abstract][Full Text] [Related]
20. 3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart. Cirrincione GM; Boluyt MO; Hwang HS; Bleske BE J Cardiovasc Pharmacol; 2006 Apr; 47(4):521-30. PubMed ID: 16680065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]